搜尋結果
2022
Chou, C. L. ,
Juan, S. H. ,
Li, C. H. ,
Chen, H. H. ,
Kao, C. C. ,
Chen, L. Y. ,
Chien, L. N. &
Fang, T. C. ,
5月 6 2022 ,
於: Frontiers in Oncology. 12 , 840142.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Liver Neoplasms
100%
Case-Control Studies
80%
Colorectal Neoplasms
79%
Taiwan
24%
Registries
19%
Lee, Y. C. G. ,
Chou, H. C. ,
Chen, Y. T. ,
Tung, S. Y. ,
Ko, T. L. ,
Buyandelger, B. ,
Wen, L. L. &
Juan, S. H. ,
3月 18 2022 ,
於: Scientific Reports. 12 ,
1 ,
p. 4673 4673.
研究成果: 雜誌貢獻 › 文章 › 同行評審
perfluorooctane sulfonic acid
100%
Carnitine
76%
Endoplasmic Reticulum Stress
71%
Autophagy
61%
Reactive Oxygen Species
51%
Chen, C. M. ,
Houng, J. Y. ,
Ko, T. L. ,
Juan, S. H. &
Chou, H. C. ,
2022 ,
於: Evidence-based Complementary and Alternative Medicine. 2022 , 3323745.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Diabetic Nephropathies
100%
Oxidative Stress
69%
Down-Regulation
66%
Kidney
40%
Diabetes Complications
38%
Wang, Y. C. ,
Juan, S. H. ,
Li, C. H. ,
Chou, C. L. ,
Chen, L. Y. ,
Chien, L. N. &
Fang, T. C. ,
9月 20 2022 ,
於: Frontiers in Medicine. 9 , 997379.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Valacyclovir
100%
Peritoneal Dialysis
72%
Renal Dialysis
57%
Chronic Kidney Failure
32%
Population
26%
2021
Yang, L. Y. ,
Tsai, M. Y. ,
Juan, S. H. ,
Chang, S. F. ,
Yu, C. T. R. ,
Lin, J. C. ,
Johnson, K. R. ,
Lim, H. G. M. ,
Fann, Y. C. &
Lee, Y. C. G. ,
12月 1 2021 ,
於: International journal of molecular sciences. 22 ,
23 , 13024.
研究成果: 雜誌貢獻 › 文章 › 同行評審
spinal cord injuries
100%
Cord
64%
Methylprednisolone
58%
Spinal Cord Injuries
50%
Time
18%
Wen, L. L. ,
Chen, Y. T. ,
Lee, Y. C. G. ,
Ko, T. L. ,
Chou, H. C. &
Juan, S. H. ,
1月 2021 ,
於: PLoS ONE. 16 ,
1 January , e0245442.
研究成果: 雜誌貢獻 › 文章 › 同行評審
perfluorooctane sulfonic acid
100%
Perfluorooctane
95%
autophagy
76%
kidney cells
68%
Oxidative Stress
63%
2020
Wang, Y. C. ,
Juan, S. H. ,
Chou, C. L. ,
Hsieh, T. C. ,
Wu, J. L. &
Fang, T. C. ,
9月 2020 ,
於: Nutrients. 12 ,
9 ,
p. 1-11 11 p. , 2708.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Protein-Restricted Diet
100%
kidney diseases
95%
low protein diet
90%
dialysis
77%
long term effects
72%
2019
Chang, C. C. ,
Huang, K. H. ,
Hsu, S. P. ,
Lee, Y. C. G. ,
Sue, Y. M. &
Juan, S. H. ,
12月 1 2019 ,
於: Scientific Reports. 9 ,
1 , 4606.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase 1
100%
Methylcholanthrene
84%
Simvastatin
79%
Renal Cell Carcinoma
53%
Epithelial Cells
47%
Lee, Y. C. G. ,
Sue, Y. M. ,
Lee, C. K. ,
Huang, H. M. ,
He, J. J. ,
Wang, Y. S. &
Juan, S. H. ,
3月 1 2019 ,
於: Phytomedicine. 55 ,
p. 255-263 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-glucopyranosyloxybutanolide
100%
AMP-activated protein kinase kinase
70%
Lipolysis
54%
Cyclic AMP-Dependent Protein Kinases
48%
Adipocytes
44%
2018
Epithelial-Mesenchymal Transition
100%
Renin-Angiotensin System
99%
Streptozocin
96%
Hyperglycemia
87%
Gerbillinae
71%
Chen, C. M. ,
Juan, S. H. ,
Pai, M. H. &
Chou, H. C. ,
8月 1 2018 ,
於: Acta Histochemica. 120 ,
6 ,
p. 525-533 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Gerbillinae
100%
Experimental Diabetes Mellitus
96%
Hyperglycemia
73%
Pulmonary Fibrosis
46%
Lung
43%
Lee, C. H. ,
Lin, Y. F. ,
Chen, Y. C. ,
Wong, S. M. ,
Juan, S. H. &
Huang, H. M. ,
11月 1 2018 ,
於: Pharmacology. 102 ,
5-6 ,
p. 262-271 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
(1-methyl-1H-indol-5-yl)-(3,4,5-trimethoxy-phenyl)-methanone
100%
2-dimethylamino-N-(1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl)acetamide
96%
Tubulin Modulators
65%
G2 Phase Cell Cycle Checkpoints
54%
Colorectal Neoplasms
31%
2017
Chang, C-C. ,
Hsu, Y-H. ,
Chou, H-C. ,
Lee, Y-C. G. &
Juan, S-H. ,
5月 1 2017 ,
於: Journal of Cellular Physiology. 232 ,
5 ,
p. 1020-1029 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-Methylcholanthrene
100%
Aryl Hydrocarbon Receptors
89%
Methylcholanthrene
88%
Nitric Oxide Synthase Type III
79%
Hypertension
45%
Teng, M. S. ,
Hsu, L. A. ,
Juan, S. H. ,
Lin, W. C. ,
Lee, M. C. ,
Su, C. W. ,
Wu, S. &
Ko, Y. L. ,
8月 1 2017 ,
於: PLoS One. 12 ,
8 , e0183187.
研究成果: 雜誌貢獻 › 文章 › 同行評審
human MIRN-1233 microRNA
100%
Growth Differentiation Factor 3
81%
growth differentiation factors
62%
Growth Differentiation Factor 15
61%
MicroRNA
49%
Chou, H. C. ,
Wen, L. L. ,
Chang, C. C. ,
Lin, C. Y. ,
Jin, L. &
Juan, S. H. ,
12月 1 2017 ,
於: Toxicological Sciences. 160 ,
2 ,
p. 217-229 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
perfluorooctane sulfonic acid
100%
Sirtuin 1
85%
Resveratrol
81%
Peroxisome Proliferator-Activated Receptors
77%
Carnitine
76%
2016
Wen, L. L. ,
Lin, C. Y. ,
Chou, H. C. ,
Chang, C-C. ,
Lo, H. Y. &
Juan, S. H. ,
5月 1 2016 ,
於: PLoS One. 11 ,
5 , e0155190.
研究成果: 雜誌貢獻 › 文章 › 同行評審
perfluorooctane sulfonic acid
100%
Peroxisome Proliferator-Activated Receptors
77%
PPAR gamma
71%
kidney cells
68%
apoptosis
59%
2015
Teng, M. S. ,
Hsu, L. A. ,
Wu, S. ,
Sun, Y. C. ,
Juan, S. H. &
Ko, Y. L. ,
4月 13 2015 ,
於: PLoS One. 10 ,
4 , e0122664.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Adiponectin
100%
adiponectin
77%
metabolic syndrome
75%
Haplotypes
51%
Metabolic Syndrome
50%
Cheng, K. T. ,
Wang, Y. S. ,
Chou, H. C. ,
Chang, C-C. ,
Lee, C. K. &
Juan, S. H. ,
5月 10 2015 ,
於: Phytomedicine. 22 ,
6 ,
p. 641-647 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-glucopyranosyloxybutanolide
100%
Lipolytic
64%
PPAR alpha
59%
AMP-Activated Protein Kinases
55%
Lipolysis
54%
2014
Chang, C. C. ,
Sue, Y. M. ,
Yang, N. J. ,
Lee, Y-H. &
Juan, S. H. ,
3月 21 2014 ,
於: PLoS One. 9 ,
3 , e92793.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Aryl Hydrocarbon Receptor Agonist
100%
Histone Deacetylase 1
84%
3-Methylcholanthrene
79%
histone deacetylase
77%
cell cycle checkpoints
73%
Lin, H. ,
Li, H. F. ,
Chen, H-H. ,
Lai, P. F. ,
Juan, S-H. ,
Chen, J. J. &
Cheng, C. F. ,
2014 ,
於: Molecular Pharmacology. 85 ,
5 ,
p. 682-691 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Activating Transcription Factor 3
100%
Beclin-1
80%
Autophagy
60%
Heart Failure
46%
Pressure
40%
Sue, Y. M. ,
Chou, H. C. ,
Chang, C-C. ,
Yang, N. J. ,
Chou, Y. &
Juan, S. H. ,
8月 4 2014 ,
於: PLoS ONE. 9 ,
8 , e104079.
研究成果: 雜誌貢獻 › 文章 › 同行評審
NFATC Transcription Factors
100%
PPAR alpha
95%
Carnitine
89%
Carboplatin
83%
Kidney
40%
Hsu, Y. H. ,
Chang, C. C. ,
Yang, N. J. ,
Lee, Y-H. &
Juan, S. H. ,
2014 ,
於: Journal of Cellular Physiology. 229 ,
10 ,
p. 1455-1465 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-Methylcholanthrene
100%
Methylcholanthrene
88%
Simvastatin
68%
Compound Mobility
53%
Endothelial Cells
51%
2013
Teng, M. S. ,
Hsu, L. A. ,
Wu, S. ,
Chou, H. H. ,
Chang, C. J. ,
Sun, Y. Z. ,
Juan, S. H. &
Ko, Y. L. ,
6月 2013 ,
於: Atherosclerosis. 228 ,
2 ,
p. 406-412 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Selectins
100%
Blood Group Antigens
82%
HDL Cholesterol
69%
Triglycerides
61%
Genes
30%
Chou, Y. ,
Lin, H. C. ,
Chen, K. C. ,
Chang, C. C. ,
Lee, W. S. &
Juan, S. H. ,
8月 2013 ,
於: British Journal of Pharmacology. 169 ,
7 ,
p. 1447-1460 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Homocysteine
100%
Folic Acid
91%
Smooth Muscle Myocytes
81%
Focal Adhesion Protein-Tyrosine Kinases
25%
Transfection
17%
Wen, H. C. ,
Kao, C. ,
Hsu, R. C. ,
Huo, Y. N. ,
Ting, P. C. ,
Chen, L. C. ,
Hsu, S. P. ,
Juan, S. H. &
Lee, W. S. ,
4月 17 2013 ,
於: PLoS One. 8 ,
4 , e61506.
研究成果: 雜誌貢獻 › 文章 › 同行評審
human umbilical vein endothelial cells
100%
Silencing RNA
88%
Human Umbilical Vein Endothelial Cells
73%
endothelial cells
70%
transfection
59%
2012
Chang, C. C. ,
Lee, P. S. ,
Chou, Y. ,
Hwang, L. L. &
Juan, S. H. ,
7月 2012 ,
於: American Journal of Pathology. 181 ,
1 ,
p. 211-221 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Aryl Hydrocarbon Receptors
100%
Methylcholanthrene
99%
Catenins
98%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
75%
Blood Vessels
45%
2011
Sue, Y. M. ,
Cheng, C. F. ,
Chou, Y. ,
Chang, C. C. ,
Lee, P. S. &
Juan, S. H. ,
4月 2011 ,
於: British Journal of Pharmacology. 162 ,
8 ,
p. 1716-1730 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Heme Oxygenase (Decyclizing)
100%
Carboplatin
82%
Apoptosis
45%
Kidney
39%
T-Lymphocytes
14%
Peng, P. H. ,
Chao, H. M. ,
Juan, S. H. ,
Chen, C. F. ,
Liu, J. H. &
Ko, M. L. ,
3月 2011 ,
於: Current Eye Research. 36 ,
3 ,
p. 238-246 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
cobaltiprotoporphyrin
100%
Heme Oxygenase-1
69%
Reperfusion Injury
57%
Pharmacology
39%
Reperfusion
37%
2010
Lin, H. ,
Sue, Y. M. ,
Chou, Y. ,
Cheng, C. F. ,
Chang, C. C. ,
Li, H. F. ,
Chen, C. C. &
Juan, S. H. ,
12月 2010 ,
於: British Journal of Pharmacology. 161 ,
7 ,
p. 1661-1676 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Carboplatin
100%
Oxidative Stress
65%
T-Lymphocytes
55%
Apoptosis
54%
Kidney
47%
Lin, H. ,
Yu, C. H. ,
Jen, C. Y. ,
Cheng, C. F. ,
Chou, Y. ,
Chang, C. C. &
Juan, S. H. ,
10月 2010 ,
於: American Journal of Pathology. 177 ,
4 ,
p. 1697-1709 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Peroxisome Proliferator-Activated Receptors
100%
Heme Oxygenase-1
97%
Adiponectin
89%
Iron
68%
Liver
42%
Sun, Y. Y. ,
Wang, C. Y. ,
Hsu, M. F. ,
Juan, S. H. ,
Chang, C. Y. ,
Chou, C. M. ,
Yang, L. Y. ,
Hung, K. S. ,
Xu, J. ,
Lee, Y-H. &
Hsu, C-Y. ,
7月 14 2010 ,
於: Journal of Neuroscience. 30 ,
28 ,
p. 9621-9630 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hypoxia-Inducible Factor 1
100%
Neurotoxins
89%
Oligodendroglia
87%
Erythropoietin
83%
Methylprednisolone
73%
Lee, F. P. ,
Jen, C. Y. ,
Chang, C. C. ,
Chou, Y. ,
Lin, H. ,
Chou, C. M. &
Juan, S. H. ,
9月 2010 ,
於: Journal of Cellular Physiology. 224 ,
3 ,
p. 837-847 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Adiponectin
100%
Cyclooxygenase 2
57%
Hepatocytes
46%
Iron
45%
Wounds and Injuries
26%
2009
Sue, Y. M. ,
Cheng, C. F. ,
Chang, C. C. ,
Chou, Y. ,
Chen, C. H. &
Juan, S. H. ,
3月 2009 ,
於: Nephrology Dialysis Transplantation. 24 ,
3 ,
p. 769-777 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
tetramethylpyrazine
100%
Heme Oxygenase (Decyclizing)
89%
Gentamicins
68%
Apoptosis
40%
Inflammation
38%
Chang, C. C. ,
Tsai, S. Y. ,
Lin, H. ,
Li, H. F. ,
Lee, Y. H. ,
Chou, Y. ,
Jen, C. Y. &
Juan, S. H. ,
10月 2009 ,
於: Cellular and Molecular Life Sciences. 66 ,
19 ,
p. 3193-3205 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Aryl Hydrocarbon Receptors
100%
Methylcholanthrene
99%
Umbilicus
86%
Cell Movement
63%
Endothelial Cells
57%
Sue, Y. M. ,
Chung, C. P. ,
Lin, H. ,
Chou, Y. ,
Jen, C. Y. ,
Li, H. F. ,
Chang, C. C. &
Juan, S. H. ,
8月 2009 ,
於: American Journal of Physiology - Cell Physiology. 297 ,
2 研究成果: 雜誌貢獻 › 文章 › 同行評審
beraprost
100%
Peroxisome Proliferator-Activated Receptors
73%
Protein Transport
67%
Protein Binding
60%
Smooth Muscle Myocytes
53%
2008
Peng, P. H. ,
Mei-Lan, K. O. ,
Chen, C. F. &
Juan, S. H. ,
12月 2008 ,
於: Clinical Science. 115 ,
11 ,
p. 335-342 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Heme Oxygenase (Decyclizing)
100%
Retinal Ganglion Cells
84%
Reperfusion Injury
71%
Adenoviridae
48%
Reperfusion
43%
Pang, P. H. ,
Lin, Y. H. ,
Lee, Y. H. ,
Hou, H. H. ,
Hsu, S. P. &
Juan, S. H. ,
4月 2008 ,
於: Journal of Cellular Physiology. 215 ,
1 ,
p. 161-171 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Aryl Hydrocarbon Receptor Agonist
100%
3-Methylcholanthrene
79%
Aryl Hydrocarbon Receptors
71%
Methylcholanthrene
71%
Umbilicus
61%
Lin, H. ,
Lee, J. L. ,
Hou, H. H. ,
Chung, C. P. ,
Hsu, S. P. &
Juan, S. H. ,
2月 2008 ,
於: Journal of Cellular Physiology. 214 ,
2 ,
p. 434-441 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Beraprost
100%
beraprost
81%
PPAR delta
75%
Epoprostenol
56%
Antiproliferative
49%
Lin, C. H. ,
Juan, S. H. ,
Wang, C. Y. ,
Sun, Y. Y. ,
Chou, C. M. ,
Chang, S. F. ,
Hu, S. Y. ,
Lee, W. S. &
Lee, Y-H. ,
3月 2008 ,
於: Journal of Neurochemistry. 104 ,
5 ,
p. 1415-1429 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dioxins
100%
Aryl Hydrocarbon Receptors
96%
Neurotoxicity
94%
Hydrocarbon
53%
Neurons
46%
Cheng, C. F. ,
Juan, S. H. ,
Chen, J. J. ,
Chao, Y. C. ,
Chen, H. H. ,
Lian, W. S. ,
Lu, C. Y. ,
Chang, C. I. ,
Chiu, T. H. &
Lin, H. ,
7月 2008 ,
於: Apoptosis. 13 ,
7 ,
p. 883-894 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pravastatin
100%
Carboplatin
87%
Cardiotoxicity
69%
Oxidative Stress
60%
Apoptosis
37%
Hsu, S. P. ,
Ho, P. Y. ,
Juan, S. H. ,
Liang, Y. C. &
Lee, W. S. ,
11月 2008 ,
於: Cellular and Molecular Life Sciences. 65 ,
23 ,
p. 3839-3850 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Progesterone
100%
Endothelial Cells
79%
Cell Proliferation
70%
Human Umbilical Vein Endothelial Cells
57%
Thymidine
26%
Lin, C. W. ,
Hou, W. C. ,
Shen, S. C. ,
Juan, S. H. ,
Ko, C. H. ,
Wang, L. M. &
Chen, Y. C. ,
2008 ,
於: Carcinogenesis. 29 ,
9 ,
p. 1807-1815 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Proto-Oncogene Proteins c-jun
100%
Quercetin
77%
Transcription Factor AP-1
73%
Tetradecanoylphorbol Acetate
73%
Extracellular Signal-Regulated MAP Kinases
72%
2007
Hsu, Y. F. ,
Lee, T. S. ,
Lin, S. Y. ,
Hsu, S. P. ,
Juan, S. H. ,
Hsu, Y. N. ,
Zhong, W. B. &
Lee, W. S. ,
4月 2007 ,
於: Molecular Carcinogenesis. 46 ,
4 ,
p. 275-283 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
magnolol
100%
Mitogen-Activated Protein Kinase 3
70%
Cell Cycle Checkpoints
58%
Colonic Neoplasms
54%
Up-Regulation
43%
Juan, S. H. ,
Chen, C. H. ,
Hsu, Y. H. ,
Hou, C. C. ,
Chen, T. H. ,
Lin, H. ,
Chu, Y. L. &
Sue, Y. M. ,
3月 2007 ,
於: Nephrology Dialysis Transplantation. 22 ,
3 ,
p. 732-739 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
tetramethylpyrazine
100%
Gentamicins
68%
Apoptosis
40%
Kidney
35%
NF-kappa B
14%
2006
Lee, M. H. ,
Jiang, C. B. ,
Juan, S. H. ,
Lin, R. D. &
Hou, W. C. ,
2月 2006 ,
於: Fitoterapia. 77 ,
2 ,
p. 109-115 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Heme Oxygenase-1
100%
Superoxides
85%
1,1-diphenyl-2-picrylhydrazyl
79%
Heme
78%
Inhibitory Concentration 50
77%
Juan, S. H. ,
Lee, J. L. ,
Ho, P. Y. ,
Lee, Y-H. &
Lee, W. S. ,
1月 13 2006 ,
於: European Journal of Pharmacology. 530 ,
1-2 ,
p. 1-8 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Aryl Hydrocarbon Receptors
100%
Methylcholanthrene
99%
Umbilicus
86%
Endothelial Cells
57%
Cell Adhesion
45%
2005
Antiapoptotic
100%
Interleukin-5
78%
Up-Regulation
50%
Cells
49%
Inhibition of Apoptosis
43%
Chao, H. H. ,
Chen, J. J. ,
Chen, C. H. ,
Lin, H. ,
Cheng, C. F. ,
Lian, W. S. ,
Chen, Y. L. ,
Juan, S. H. ,
Liu, J. C. ,
Liou, J. Y. ,
Chan, P. &
Cheng, T-H. ,
5月 2005 ,
於: Heart. 91 ,
5 ,
p. 664-669 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Endothelin-1
100%
Angiotensin II
89%
Fibroblasts
68%
Gene Expression
55%
Extracellular Signal-Regulated MAP Kinases
42%
Juan, S. H. ,
Cheng, T-H. ,
Lin, H. C. ,
Chu, Y. L. &
Lee, W. S. ,
1月 1 2005 ,
於: Biochemical Pharmacology. 69 ,
1 ,
p. 41-48 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Resveratrol
100%
Heme Oxygenase-1
92%
Heme
73%
Smooth Muscle Myocytes
69%
NF-kappa B
53%
Huang, H. M. ,
Liang, Y. C. ,
Cheng, T-H. ,
Chen, C. H. &
Juan, S. H. ,
2005 ,
於: Annals of the New York Academy of Sciences. 1042 ,
p. 349-356 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Resveratrol
100%
Wine
96%
Heme
73%
Vessel
67%
Blood
61%